KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) Return on Invested Capital (2018 - 2026)

Moderna (MRNA) has disclosed Return on Invested Capital for 9 consecutive years, with 0.42% as the latest value for Q1 2026.

  • For Q1 2026, Return on Invested Capital fell 7.0% year-over-year to 0.42%; the TTM value through Mar 2026 reached 0.42%, down 7.0%, while the annual FY2025 figure was 0.31%, 0.0% changed from the prior year.
  • Return on Invested Capital hit 0.42% in Q1 2026 for Moderna, down from 0.34% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.89% in Q1 2022 and bottomed at 0.49% in Q2 2024.
  • Average Return on Invested Capital over 5 years is 0.05%, with a median of 0.33% recorded in 2025.
  • Year-over-year, Return on Invested Capital surged 72bps in 2022 and then tumbled -86bps in 2023.
  • Moderna's Return on Invested Capital stood at 0.42% in 2022, then tumbled by -185bps to 0.35% in 2023, then increased by 7bps to 0.33% in 2024, then fell by -2bps to 0.34% in 2025, then decreased by -24bps to 0.42% in 2026.
  • According to Business Quant data, Return on Invested Capital over the past three periods came in at 0.42%, 0.34%, and 0.36% for Q1 2026, Q4 2025, and Q3 2025 respectively.